Cargando…
High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis
BACKGROUND: The effectiveness of high-flow nasal cannula oxygen therapy (HFNC) in patients with acute respiratory failure due to COVID-19 remains uncertain. We aimed at assessing whether HFNC is associated with reduced risk of intubation or mortality in patients with acute respiratory failure due to...
Autores principales: | Le Pape, Sylvain, Savart, Sigourney, Arrivé, François, Frat, Jean-Pierre, Ragot, Stéphanie, Coudroy, Rémi, Thille, Arnaud W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667189/ https://www.ncbi.nlm.nih.gov/pubmed/37994981 http://dx.doi.org/10.1186/s13613-023-01208-8 |
Ejemplares similares
-
High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure
por: Frat, Jean-Pierre, et al.
Publicado: (2022) -
Preoxygenation with non-invasive ventilation versus high-flow nasal cannula oxygen therapy for intubation of patients with acute hypoxaemic respiratory failure in ICU: the prospective randomised controlled FLORALI-2 study protocol
por: Frat, Jean-Pierre, et al.
Publicado: (2017) -
High-flow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure: an observational cohort study
por: Coudroy, Rémi, et al.
Publicado: (2016) -
High flow nasal cannula oxygen therapy in immunocompromised patients with acute hypoxemic respiratory failure
por: Frat, J-P, et al.
Publicado: (2015) -
High-flow nasal cannula oxygen therapy versus noninvasive ventilation versus in immunocompromised patients with acute respiratory failure
por: Coudroy, R, et al.
Publicado: (2015)